29th Jul 2021 15:37
Indivior PLC - Virginia, US-based opioid-addiction drug maker - Reports first half profit hike and USD100 million buyback. Pretax profit swings to GBP119 million for six months ended June 30 from loss of GBP171 million in same period last year, net revenue climbs 25% to GBP381 million from GBP303 million.
"Looking forward, our number one priority continues to be capturing the full transformational value of SUBLOCADE, and it is gratifying to see further uptake of this key asset in targeted Organized Health Systems, including a USD7 million order from a criminal justice system that we believe is pioneering treatment of incarcerated individuals suffering from opioid use disorder," says Chief Executive Mark Crossley.
No proposed dividend in line with last year. USD100 million share buyback will start shortly with December 31 maturity date.
Current stock price: 156.90 pence, up 5.8% on Thursday afternoon
Year-to-date change: up 44%
By Josie O'Brien; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Indivior